Related Experiment Video
Updated: Jul 14, 2026

Intravenous Injections in Neonatal Mice
Published on: November 11, 2014
Impact of multiple injections on immunization rates among vulnerable children
M S Kolasa1, T J Petersen, E W Brink
1Immunization Services Division, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA. mkolasa.cdc.gov
Insights
New infant vaccination schedules using inactivated polio vaccine (IPV) and diphtheria, tetanus, and acellular pertussis vaccine (DTaP) led to higher immunization coverage by 12 months. Provider and parent acceptance of increased injections was high.
Area of Science:
- Pediatrics
- Immunology
- Public Health
Background:
- In 1997, the Advisory Committee on Immunization Practices (ACIP) updated infant vaccination guidelines.
- Recommendations included switching from oral polio vaccine (OPV) to inactivated polio vaccine (IPV) and adopting diphtheria, tetanus, and acellular pertussis vaccine (DTaP).
- These changes increased the number of infant injections at 2- and 4-month visits.
Purpose of the Study:
- To evaluate the implementation of new IPV and DTaP vaccination recommendations.
- To assess the impact of these changes on infant immunization coverage levels.
Main Methods:
- Immunization coverage was analyzed in public clinics across three urban areas.
- Data was collected before and after the 1997 recommendations.
- One pre-recommendation and three post-recommendation infant cohorts were tracked up to 12 months of age.
Main Results:
- Pre-recommendation infants primarily received OPV and DTP with 1-2 injections.
- Post-recommendation infants predominantly received IPV and DTaP, involving 3-4 injections.
- Immunization coverage up-to-date at 12 months was slightly higher in the post-recommendation cohorts.
Conclusions:
- Healthcare providers quickly adopted IPV and DTaP, replacing OPV and DTP.
- Infants receiving IPV/DTaP showed higher 12-month coverage compared to OPV/DTP recipients.
- High acceptance of four injections per visit was observed among providers and parents, prompting assessment of acceptance for potential future five-injection schedules.
Background:
In 1997, the Advisory Committee on Immunization Practices (ACIP) recommended a switch from oral polio vaccine (OPV) to inactivated polio vaccine (IPV) for the first two infant doses. The ACIP also recommended use of diphtheria, tetanus, and acellular pertussis vaccine (DTaP) for infants. These recommendations resulted in two additional injections at the 2- and 4-month immunization visits. This study evaluates the implementation of new IPV and DTaP immunization recommendations and their impact on immunization coverage levels.
Methods:
Immunization coverage was assessed in public clinics in three urban areas before and after the recommendations. One pre- and three post-recommendation cohorts were followed to 12 months of age.
Results:
Almost all (> or = 88%) infants in the pre-recommendation cohort received OPV, DTP, and only one or two injections. Almost all (> or = 78%) infants in the post-recommendation cohorts received IPV, DTaP, and three or four injections. The percentage of infants in the post-recommendation cohorts up-to-date for immunizations at 12 months of age was slightly higher than those in the pre-recommendation cohort.
Conclusions:
Providers rapidly switched from OPV and DTP to IPV and DTaP. Coverage at 12 months of age was higher among IPV/DTaP recipients than among OPV/DTP recipients. Provider and parent acceptance of four injections at a visit was high. The recent pneumococcal conjugate vaccine recommendations potentially add a fifth injection at 2 and 4 months of age. Acceptance or rejection of five injections by providers and parents needs early assessment.
More Related Videos
Related Concept Videos
Vaccinations
Factors Affecting Drug Response: Overview
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Drug Accumulation During Multiple Dosing: Repetitive IV Injections
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Smallpox

